Survey: China, Malaysia demonstrate strong pharma growth

05/14/2013 | BioSpectrum Asia · BioSpectrum Asia

Despite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will continue to expand and attract private investment. Malaysia, too, is rapidly becoming a center of pharmaceutical and medical device manufacturing, with estimates that the medtech market there will hit $2.8 billion in four years. The assessments of both countries come from the BioSpectrum Asia Top 20 Survey.

View Full Article in:

BioSpectrum Asia · BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX